Back to search
FDAFDA · Food and drugs·Recall number D-0155-2020

Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A, NDC 0378-5185-93

Published November 6, 2019 · Recall initiated: October 18, 2019

Summary

FDA records drug Class II recall D-0155-2020, published November 6, 2019 and initiated October 18, 2019. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4,272 bottles; Lot: Lot #: 3089793, Exp. Date September 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification: Low out of specification dissolution results.

What to do

Voluntary: Firm initiated · Letter

Get an email if PRASUGREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRASUGREL
Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide within the United States
UPC
0303785185932
Lot
Lot #: 3089793, Exp. Date September 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A, NDC 0378-5185-93 recalled?

Yes. FDA published recall D-0155-2020 on November 6, 2019. Reported hazard: Failed Dissolution Specification: Low out of specification dissolution results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRASUGREL. UPC: 0303785185932.